Introduction {#s1}
============

Permanent pacemaker (PPM) implantation after cardiac surgery is required in 0.4-6% of patients depending on cardiac surgery type \[[@R01]\].

In recent times, the incidence of postoperative PPM implantation has decreased due to improvements in surgical techniques, technological innovations and enhanced understanding of the mechanisms of injury, which generate the arrhythmia \[[@R15]\]. On the other hand, some studies have shown an increased incidence of PPM implantation after cardiac surgery after the year 2000 \[[@R16]\].

Identifying the patients who are at high risk for postoperative PPM implantation is important as it may reduce morbidity and postoperative hospital stay \[[@R12]\]. Several predictors of postoperative PPM implantations have been studied and observed; however, the risk factors for PPM implantation have been inconsistent across various studies. Our research aim was to determine the incidence and predictors for increased risk of postoperative PPM implantation in coronary artery bypass surgery (CABG) and valve replacement surgeries.

Materials and Methods {#s2}
=====================

We performed a retrospective chart review of 1,234 patients who underwent CABG, valve replacement surgery, or both at the Heart Centre, King Faisal Specialist Hospital and Research Centre between January 2007 and December 2009.

Inclusion criteria consisted of all CABG, valve replacement surgery, or both. Twenty patients received PPM within 90 days after cardiac surgery. The 1,214 remaining patients served as controls.

The demographic, clinical, preoperative, operative, and early postoperative data were obtained from the cardiac surgery database at our Heart Centre. This prospective database is part of an ongoing database of patients undergoing cardiac surgery at our center.

The perioperative electrocardiograms (ECGs) were collected routinely in the MUSE Cardiology Information System (GE Healthcare) which is the ECG database management system in our hospital. The ECG data of patients receiving a PPM were compared to those of the control group.

Patients with an indication for pacemaker implantation before the cardiac surgery and patients who underwent postoperative implantable cardioverter defibrillator (ICD) implantation who did not have indication for the permanent pacing were excluded from the study.

Data from pacemaker clinic follow-up visits were used to determine pacemaker dependency. The underlying rhythm was obtained by programming the pacemaker to VVI rate of 40 beats per minute during the patient's visit to the pacemaker outpatient clinic. Pacemaker dependency was defined as continuous pacing with lowering pacemaker rate to 40 beats per minutes for at least 10 s \[[@R12]\].

Statistical analysis {#s2a}
--------------------

Descriptive statistics for the continuous variables were reported as mean ± standard deviation and categorical variables were summarized as frequencies and percentages. The continuous variables of the two groups of patients were compared by Student's independent *t*-test, while the categorical variables were compared by Chi-square test. Logistic multivariate regression analysis was used to define the major predictors of requiring PPM postoperatively. The statistical level of significance was set at P \< 0.05.

Ethical consideration {#s2b}
---------------------

The study was conducted in accordance with the Helsinki Declaration as revised in 2013 and it was approved by research ethics board (REB) in our hospital prior to data collection and analysis.

Results {#s3}
=======

Patients' age was 46.65 ± 16 years, and 59% were males. CABG was performed in 575 (46.6%) cases, aortic valve replacement in 263 (21.3%), mitral valve replacement in 333 (27%), and tricuspid valve replacement in 76 patients (6.2%) ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Twenty patients (1.6%) required implantation of a PPM postoperatively. Indications for PPM implantation included complete atrioventricular (AV) block in 13 patients (65%), sick sinus syndrome with symptomatic bradycardia in three (15%), and atrial fibrillation (AF) with a slow ventricular rate in four (20%) ([Fig. 1](#F1){ref-type="fig"}). The types of cardiac surgery in PPM patients are shown in [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}. The timing of pacemaker implantation ranged from 7 to 73 days after surgery, with a mean of 17.65 ± 14 and median of 13.5 days. The delay in implantation in two patients was due to prolonged stay in the intensive care unit (ICU) and active infection. Two patients were discharged with junctional rhythm because they did not initially accept PPM implantation. Later on, when they presented for follow-up with no improvement in their rhythm, these patients did undergo PPM implantation. With exclusion of these two patients who were implanted on another admission, the mean time to PPM implantation was 14.89 ± 5.4 days, and median 13.5 days.

###### Preoperative Data

                                             PPM, no. (%)   Non-PPM, no. (%)   P value
  ------------------------------------------ -------------- ------------------ ---------
  N                                          20             1,214              
  Demographic data                                                             
    Age                                      41.6 ± 15.6    51.3 ± 16.4        0.009
    Age \> 65 years                          2 (10%)        279 (23%)          0.170
    Gender (Male)                            11 (55.0%)     721 (59.4%)        0.692
    Hypertension                             6.0 (30%)      576 (47.4%)        0.121
    Diabetes                                 7.0 (35%)      522 (43%)          0.473
    Dyslipidemia                             0.0 (0%)       333 (27.4%)        0.006
    Pulmonary hypertension                   12 (60%)       240 (19.8%)        0.000
    Peripheral vascular disease              1.0 (5%)       25 (2.1%)          0.364
    Old CVA                                  1.0 (5%)       42 (3.5%)          0.709
    Renal impairment (creatinine \> 1.5)     1.0 (5%)       116 (9.6%)         0.490
  LV systolic function (LVEF)                                                  
    Normal \> 55%                            0.0 (0%)       57 (4.7%)          0.321
    Mildly impaired 45-55%                   0.0 (0%)       98 (8.1%)          0.185
    Moderately impaired 35-44%               4.0 (20%)      187 (15.4%)        0.573
    Moderately to severely impaired 25-34%   10 (50%)       449 (37%)          0.232
    Severely impaired \< 25%                 6.0 (30%)      419 (34.5%)        0.673
  Coronary artery disease                                                      
    Left main stenosis (\> 50%)              0 (0%)         168 (13.8%)        0.072
    Proximal LAD stenosis (\> 70%)           1 (5%)         520 (42.8%)        0.001
    LCX                                      1 (5%)         453 (37.3%)        0.003
    RCA                                      3 (15%)        460 (37.9%)        0.036
  Drugs                                                                        
    β-blockers                               9 (45%)        543 (44.7%)        0.981
    Calcium channel blockers                 0 (0%)         51 (4.2%)          0.796
    Digoxin                                  1 (5%)         47 (3.9%)          0.796
    Antiarrhythmic                           0 (0%)         9 (0.7%)           0.699

PPM: permanent pacemaker; non-PPM: non-permanent pacemaker; CVA: cerebrovascular accident; LV: left ventricle; EF: ejection fraction; LAD: left anterior descending artery; LCX: left circumflex; RCA: right coronary artery.

###### Operative Data

                             PPM            Non-PPM         P value
  -------------------------- -------------- --------------- ---------
  N                          20             1,214           
  Elective                   19 (95%)       1,125 (92.7%)   0.691
  Emergency                  1.0 (5%)       89 (7.3%)       0.691
  Reoperation                12 (60%)       301 (24.9%)     0.000
  CABG alone                 3.0 (15%)      572 (47.2%)     0.004
  Valve alone                19 (95%)       703 (58.1%)     0.001
  Combined                   2 (10%)        123 (10.2%)     0.478
  MVR                        10 (50%)       323 (26.6%)     0.001
  AVR                        6.0 (30%)      257 (21.2%)     0.339
  TVR                        7.0 (35%)      69 (5.7%)       0.000
  PVR                        0.0 (0%)       16 (1.3%)       0.605
  BPT (min)                  169.8 ± 77.2   125.3 ± 66.5    0.003
  XCT (min)                  125 ± 65.3     89 ± 48         0.001
  XCT \> 120 min             3.3 ± 2        3 ± 2           0.622
  Minimum temperature (°C)   32 ± 1.7       32 ± 4.8        0.687
  Cold cardioplegia          2 (10%)        196 (16.1%)     0.458

PPM: permanent pacemaker; non-PPM: non-permanent pacemaker; CABG: coronary artery bypass grafting; AVR: aortic valve replacement; MVR: mitral valve replacement/repair; AVR: aortic valve replacement/repair; TVR: tricuspid valve replacement/repair; PVR: pulmonic valve replacement/repair; BPT: cardiopulmonary bypass time; XCT: aortic cross-clamp time.

![Indications of pacemaker. CHB: complete heart block; AF: atrial fibrillation; VR: ventricular rate; SSS: sick sinus syndrome.](cr-07-123-g001){#F1}

![Type of surgery in the patients with permanent pacemaker. CABG: coronary artery bypass surgery; MV: mitral valve; TV: tricuspid valve; AV: aortic valve; R: replacement; rep: repair.](cr-07-123-g002){#F2}

![First vs. redo surgery in patients with permanent pacemakers.](cr-07-123-g003){#F3}

[Table 1](#T1){ref-type="table"} shows the preoperative clinical profile of PPM patients compared with non-PPM patients. Patients with PPM were younger than those who did not require PPM. Dyslipidemia was more frequent in the non-PPM group. There were no significant differences in gender, hypertension, diabetes mellitus, peripheral vascular disease, old cerebrovascular accidents (CVAs), and left ventricular ejection fraction between the two groups. Pulmonary hypertension (P-HTN) was more prevalent in PPM patients. The presence of coronary artery disease (left anterior descending artery (LAD), left circumflex (LCX), and right coronary artery (RCA)) was seen more in the non-PPM group. The use of beta-blockers, calcium channel blockers, digoxin, and antiarrhythmic medications was equal in the two groups.

Most of the surgeries (95%) were done on an elective basis. Reoperation surgeries were performed in 313 patients (25.3%) ([Table 2](#T2){ref-type="table"}).

[Table 3](#T3){ref-type="table"} shows the preoperative ECG characteristics of the patients. Patients requiring PPM had a higher incidence of preoperative conduction disorders in the form of left bundle branch block (LBBB), and first-degree AV block.

###### Preoperative Electrocardiogram (ECG)

                     PPM, no. (%)   Non-PPM, no (%)   P value
  ------------------ -------------- ----------------- ---------
  N                  20             1,214             
  AFIB               5 (25%)        179 (14.7%)       0.202
  Any BBB            3 (15%)        91 (7.5%)         0.213
  LBBB               2 (10%)        28 (2.3%)         0.027
  RBBB               2 (10%)        64 (5.3%)         0.351
  First-degree AVB   4 (20%)        66 (5.4%)         0.005

PPM: permanent pacemaker; non-PPM: non-permanent pacemaker; AF: atrial fibrillation; BBB: bundle branch block; LBBB: left bundle branch block; RBBB: right bundle branch block; AVB: atrioventricular block.

Patients requiring PPM had a longer overall postoperative hospitalization, but not necessarily a longer ICU stay. There was no difference in mortality between the two groups ([Table 4](#T4){ref-type="table"}).

###### Postoperative Data

                              PPM, no (%)   Non-PPM, no (%)   P value
  --------------------------- ------------- ----------------- ---------
  N                           20            1,214             
  Perioperative MI            0.0 (0%)      267 (22%)         0.018
  Elevated Trop-T (\> 0.01)   8.0 (40%)     689 (56.8%)       0.134
  ICU stay (days)             6.80 ± 6.0    9 ± 4.74          0.311
  Hospital stay (days)        18.1 ± 11.5   12.3 ± 8.5        0.000
  Mortality                   0 (0.0%)      92 (7.6%)         0.201

PPM: permanent pacemaker; non-PPM: non-permanent pacemaker; MI: myocardial infarction; Trop-T: troponin-T; ICU: intensive care unit.

Predictors for PPM requirement by multivariate analysis were the presence of P-HTN, reoperation surgery, and LBBB (P \< 0.05) ([Table 5](#T5){ref-type="table"}).

###### Predictors of Permanent Pacemaker Implantation

  Variables     P value   OR      95% confidence interval of the difference   
  ------------- --------- ------- ------------------------------------------- --------
  LBBB          0.042     2.0     1.32                                        5.54
  P-HTN         0.001     5.08    1.941                                       13.296
  Reoperation   0.001     4.515   1.828                                       11.15

LBB: left buddle branch block; P-HTN: pulmonary hypertension.

Long-term follow-up was available in 18 pacemaker patients with follow-up periods ranging from 35 to 109 months and a mean of 84.5 ± 30 months. Eleven patients (61%) were PPM dependent.

Discussion {#s4}
==========

The requirement of PPM in our series was 1.6%, which is consistent with what has been reported previously \[[@R03], [@R12]\].

The predictors for PPM post-cardiac surgery will be discussed in the order of preoperative, operative, and postoperative periods.

Preoperative predictors {#s4a}
-----------------------

Our patients were younger than what has been reported in previous studies \[[@R01]\] due to valve surgery for young patients with rheumatic heart disease.

In our study, there was no difference in gender between the PPM and the non-PPM groups, unlike some previous studies which showed female gender as a predictor for PPM implantation \[[@R03], [@R05], [@R08]\].

Age above 75 years at the time of surgery was reported previously as a risk factor for requiring a PPM \[[@R01], [@R03], [@R04], [@R13], [@R16], [@R17]\], but this was not the case in our patients. Patients with P-HTN were found to have a higher risk of requiring PPM postoperatively. This was also noted in one previous study \[[@R07]\].

The use of rate lowering cardiac medications (e.g., beta-blockers, calcium channel blockers, digoxin, and anti-arrhythmic medications) is one of the suggested mechanisms contributing to conduction system damage postoperatively. Some studies showed that preoperative use of antiarrhythmic medications, like digoxin \[[@R07]\], calcium channel blockers \[[@R08]\], amiodarone and sotalol \[[@R11]\], increased the risk for PPM postoperatively, but we found no relation between preoperative medications and the requirement of PPM in our patients.

The presence of conduction system disease preoperatively \[[@R01], [@R07]\], right bundle branch block (RBBB) or LBBB \[[@R08], [@R14]\], LBBB alone \[[@R02], [@R12]\], RBBB alone \[[@R13], [@R17]\], first-degree AV block \[[@R14]\] or left anterior fascicular block (LAFB) \[[@R14]\] was found to be a predictor for requiring PPM postoperatively. In our patients, LBBB was found to be a significant predictor. Preoperative non-sinus rhythm \[[@R03], [@R18]\] or AF \[[@R05]\] were risk factors in some previous studies but not in our series.

The cardiac conduction system is susceptible to damage during cardiac surgery. The main physiopathological mechanisms involved in the development of cardiac conduction disorders postoperatively are myocardial ischemia, inadequate cardiac protection during surgery, and direct surgical injury \[[@R15]\]. Ischemia may be more common in patients with left main or proximal LAD disease \[[@R19], [@R20]\] but this was not the case in our patients.

Operative predictors {#s4b}
--------------------

Mechanical trauma to the conduction system arising secondary to valve operation, or other surgeries close to the AV node, is another risk factor for AV node conduction disorder \[[@R15]\]. The need for PPM postoperatively is more common in valve surgeries especially aortic, mitral and tricuspid valve surgeries \[[@R01], [@R03], [@R04], [@R09], [@R12], [@R16], [@R18]\]. We found that of all valve surgeries in general, mitral valve and tricuspid valve surgeries had a higher risk of requiring PPM, but with multivariate analysis, these did not emerge as independent risk factors.

In addition to coronary artery disease, ischemic injury of the sinus node or other parts of the conduction system might occur during any cardiac procedure because of inadequate myocardial protection during surgery \[[@R15]\].

Prolonged cardiopulmonary bypass time and cross-clamp time have been found in this study as well as in previous studies \[[@R08], [@R11], [@R16], [@R18]\] to be associated with postoperative PPM requirement. Cold blood cardioplegia was also found to be a risk factor in previous studies \[[@R03]\], but not in our current study.

About 35% of PPM patients in this study were undergoing redo surgery. Reoperation was found in this study to be a significant risk as it was in previous studies \[[@R03], [@R18]\].

Postoperative predictors {#s4c}
------------------------

Postoperative conduction disturbances \[[@R07]\] and high-grade AV block \[[@R06]\] were found to increase risk of PPM postoperatively. Most of our patients who required PPM had postoperative complete heart block (CHB).

In our patients, time to pacemaker implant was longer than what has been reported previously \[[@R21]\] because we enrolled patients with pacemaker implantation up to 3 months postoperatively.

About 61% of our patients were pacer dependent on long-term follow-up, which is similar to what has been reported before \[[@R12], [@R22]\].

From a practical point of view, the decision regarding which patient will require PPM and when to implant the device are the most important clinical questions. According to the American College of Cardiology, the American Heart Association and Heart Rhythm Society guidelines, PPM implantation is indicated for third-degree and advanced second-degree AV block, at any anatomic level, associated with postoperative AV block which is not expected to resolve after cardiac surgery (level of evidence: C) \[[@R23]\].

The decision about PPM implantation and its timing is left for treating physicians' discretion. We believe that patients with high-risk factors need to be counseled preoperatively about their risk of requiring PPM postoperatively. Additionally, implantation of the pacemaker early after cardiac surgery is recommended for conduction system disorders which are unlikely to recover. Placing epicardial PPM leads in identified at-risk patients during the surgery, especially with tricuspid valve intervention, may also be helpful.

Limitations of the study {#s4d}
------------------------

The main limitation in this study is the small number of patients who underwent PPM implantation after cardiac surgery. As a retrospective analysis, the study suffers from a number of limitations that should be considered when interpreting the results: the absence of a prospective validation of the model, the lack of sufficient information on annular calcification and root dilatation, operative data such as root replacement, and extent of perioperative annular debridement, all of which have been identified in earlier studies as predictors of PPM implantation \[[@R18]\].

Conclusion {#s4e}
----------

Patients at high risk for PPM implantation after cardiac surgery include those with the presence of P-HTN, reoperation surgeries, and LBBB. Of those receiving a PPM, about 40% will recover at least partially at long-term follow-up. We recommend preoperative assessment for risk of requiring PPM postoperatively to counsel patients about this risk and early PPM implantation in high-risk patients who are dependent on temporary pacemaker after surgery.
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